At a glance
ClinicalIndex Comparison RecordN/ACompleted· 6,061 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study - A Study to Improve Precision in Amyloid PET Coverage and Patient Care
In Brief
An observational study for Alzheimer's Disease and 2 related conditions. Completed, enrolled 6,061 participants across 1 site.
Detailed Summary
New IDEAS is an observational, open-label, longitudinal cohort study designed to address the requirements of the CED provisions of the NCD on beta-amyloid PET. Building on the initial Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) study, New IDEAS will evaluate the association between amyloid PET and patient-centered outcomes in an expanded and more ethnoracially and clinically diverse group of Medicare participants presenting with cognitive impairment.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAlzheimer's Disease, Dementia, Mild Cognitive Impairment
CountriesUnited States
CollaboratorsAlzheimer's Association
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedJun 2020
Enrollment StartDec 2020
Primary CompletionDec 2024
TodayJul 2026
First PostedJun 11, 2020
Enrollment StartDec 17, 2020
Primary CompletionDec 31, 2024
TodayJul 2, 2026
Enrollment to primary: 4.0 yearsPosted 6.1 years ago